Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2026
Principal Office: Wixom, Michigan
Exchange: Nasdaq Capital Market
This filing serves as a Regulation FD disclosure to make an updated corporate presentation available to the public. The document does not contain audited financial statements or operational results for a specific reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K filing is limited to the disclosure of a corporate presentation (Exhibit 99.1) and does not include specific financial data points within the body of the report.
Material Changes
No material changes to financial performance or operations are reported in this document. The sole material event is the release of an updated corporate presentation on May 7, 2026.
Guidance, Outlook, and Risks
Management Commentary: The company has released an updated corporate presentation. The content of this presentation is incorporated by reference as Exhibit 99.1 but is not detailed in the text of this 8-K.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, unless expressly incorporated by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for specific financial guidance, product updates, and strategic outlook not included in this summary.
- Verify the trading status of RMTI on the Nasdaq Capital Market.
- Confirm that the corporate presentation has been accessed via the SEC EDGAR database or the company's investor relations website.
- Note that this filing does not constitute a formal earnings release or financial statement update.